Liver Transplantation:
Information
on allocation of livers, recurrent HCV after transplantation, effect of
race/ethnicity, immunosuppressant drugs, post transplant HCV disease progression,
and pediatric issues.
·
Allocation/General
o 594. Experience with Pre-Recovery Liver Biopsies in Potential Deceased
Liver Donors (updated October 29, 2006)
o 773. Can we expand the pool of organ donors? Use of
livers from anti-HBc+ and/or anti-HCV+ organ donors (updated October 31,
2006)
·
Allocation/MELD
o 580. Effects on survival of listing vs not listing patients with low MELD
scores (updated October 29, 2006)
o 581. Impact of MELD Allocation on Post-OLT Renal
Failure: Analysis of the UNOS Database (updated October 31,
2006)
o 604. MELD-XI: a rational approach to “sickest first” liver transplantation
in cirrhotic patients requiring anticoagulant therapy (updated October 29,
2006)
o 608. MELD score and serum sodium in the prediction of survival of patients
with cirrhosis awaiting liver transplantation (updated October 29,
2006)
o 616. Cost Analysis of Liver Transplantation According to MELD Score
(updated
October 29, 2006)
o 626. Renal Insufficiency after Liver Transplantation in the MELD Era
Compared to the Pre-MELD Era (updated November 1, 2006)
o 636. Age, creatinine and liver function but not MELD predict 6-month
survival after liver transplantation: clinical and economic considerations
(updated
October 29, 2006)
o 712. Etiology of cirrhosis has an impact on survival predicted by
MELD-score (updated October 29, 2006)
o 747. The Model for End-stage Liver Disease (MELD) Score is Predictive of
Intensive Care Unit (ICU) Mortality in Patients with Cirrhosis (updated October 30,
2006)
·
Allocation/MILAN
·
General
o 502. Simultaneous Provision of Pre-operative Palliative
Care for Patients Awaiting Liver Transplantation (updated October 29,
2006)
o 503. Nursing attitudes towards liver transplant: Gap
between perceptions and accepted standards (updated October 29,
2006)
o 508. Body Composition Analysis in Peri Transplant
Patients (updated October 29, 2006)
o 579. Effect of gender mismatch on acute cellular rejection and graft
failure in liver transplant recipients (updated October 29,
2006)
o 618. Does pre-transplant abstinence duration influence the results of
liver transplantation for alcoholic liver disease : an attempt of meta-analysis
(updated
October 29, 2006)
o 629. Transjugular Intrahepatic Portosystemic Shunts (TIPS) are Associated
with a High 1-year Mortality in Liver Transplant Recipients (updated October 31,
2006)
o 637. Rate Of Progression Of Portopulmonary Hypertension Over A Short Time
Interval In Patients Awaiting Liver Transplant (updated October 29,
2006)
·
Immunosuppression
o 583. Mycophenolate mofetyl (MMF) monotherapy is an attractive strategy in
liver transplant recipients with severe side effects of calcineurin inhibitors
(CNI) (updated October 29, 2006)
o 602. Tacrolimus versus Cyclosporine Based Immunosuppression in Hepatitis C
Patients after Liver Transplantation: Long-Term Follow-up of a Randomized
Controlled Trial (updated October 29, 2006)
o 611. Steroid-free Immunosuppression in Pediatric Liver Transplantation: A
pilot study examining efficacy for prevention of graft rejection (updated October 29,
2006)
·
Liver Cancer
·
Living Liver Donors
o 10. Outcomes of adult living donor vs. deceased donor
liver transplantation from the time of listing
o 642. Histological abnormalities found on liver biopsies
of appearently healthy potential liver donors (updated October 29,
2006)
o 643. HLA and Living-Donor Liver Transplantation
Outcomes – An Analysis of the OPTN Database
o 644. Evaluation for hepatic steatosis in Japanese
living liver donors and outcome of dietary intervention (updated October 29,
2006)
o 646. Liver regeneration in living donors of right and
left liver grafts until 1 year
o 648. Comparison of Complication Rates in Recipients of
Living Donor and Deceased Donor Liver Transplants: Findings from the Adult to
Adult Living Donor Liver Transplantation Cohort Study (A2ALL) (updated October 29,
2006)
o 649. The Impact of a Donor Advocacy Committee on the
Evaluation Process of Living Liver Donors (updated October 29,
2006)
·
Pediatric
o 603. Growth and final height after pediatric liver transplantation in
relation to age and underlying disease (updated October 29,
2006)
o 662. Liver Injury From Repeated Dosing of Acetaminophen
(APAP) in Pediatric Patients (updated October 29, 2006)
o 673. Growth Patterns in Children Following Liver
Transplantation (updated October 29, 2006)
·
Post Transplant
o 7. THE PAN-Caspase Inhibitor, IDN-6556, Attenuates
Human Liver Preservation Injury
o 590. Post-Transplant Ascites Typically Occurs in the Absence of
Significant Fibrosis (updated October 29, 2006)
o 592. Outcome of liver transplantation in patients with glutathione
S-transferase T1 donor/recipient mismatch and de novo immune hepatitis
(updated
October 29, 2006)
o 597. Sexual dysfunction in female patients before and after liver
transplantation (LT) (updated October 29, 2006)
o 606. The Development of De Novo Autoimmune Hepatitis (Immune-Mediated
Hepatitis) and its Effect on Outcome in Patients With HCV Post-Liver
Transplantation (updated October 29, 2006)
o 609. Predictors of Employment in Liver Transplant Recipients
o 1298. Increased activity of regulatory T cells in
recurrent hepatitis C after liver transplantation.
o
Recurrence
§
229. HCV infection is associated with progressive
insulin resistance in liver transplant recipients
§
610. CCR2 V64I Polymorphism: A risk factor for patients
suffering HCV after orthotopic liver transplantation (updated October 29,
2006)
§
633. The Development of Hepatic Granulomas in Patients
Receiving Pegylated Interferon Therapy for Recurrent HCV Post Liver
Transplantation (updated October 29, 2006)
§
776. Recurrence risk score predicts cumulative increase
in hepatitis C recurrence after liver transplantation (updated October 30,
2006)
§
778. Sustained Viral Response Using Peg IFN alfa-2b
Plus Ribavirin in Patients with Recurrent Hepatitis C after Liver
Transplantation (updated October 30, 2006)
§
780. Impact of Extended Criteria Donor on Hepatitis C
recurrence following Liver Transplantation (updated October 30,
2006)
§
784. Steatosis In Post Transplant Liver Biopsies May
Herald Recurrence Of Hepatitis C Genotype 3
§
787. Impact of the recurrence of hepatitis C in quality
of life after liver transplantation
·
Race/Ethnicity